HAEVN
LIVE

Serial Number

99020243

Owner

Ionis Pharmaceuticals, Inc.

Attorney

Brian Focarino

First Use Date

Feb 19, 2025

Filing Date

Jan 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HAEVN Trademark

Serial Number: 99020243

HAEVN is a trademark filed by Ionis Pharmaceuticals, Inc. on January 27, 2025. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ionis Pharmaceuticals, Inc. (10 trademarks)

2855 Gazelle Court
Carlsbad, CA 92010

Entity Type: 03

Trademark Details

Filing Date

January 27, 2025

Registration Date

Not Registered

First Use Anywhere

February 19, 2025

First Use in Commerce

February 19, 2025

Goods & Services

Providing healthcare information, medical information, and pharmaceutical information online, by telephone, and through distribution of printed healthcare materials to healthcare providers, patients, physicians, medical office staff, pharmaceutical prescribers, caregivers, and pharmacies regarding patient access to and reimbursement for pharmaceuticals and safe and appropriate use and distribution of pharmaceuticals; providing healthcare information; medical information services; providing a website featuring medical information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; medical consulting services in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; healthcare services, namely, providing an online database comprised of medical and healthcare information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune lymphoproliferative, asthma, and rare diseases and disorders, and collecting data and information on hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2026 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 30, 2025 RCSC
AMENDMENT TO USE PROCESSING COMPLETE
Dec 10, 2025 AUPC
USE AMENDMENT FILED
Dec 10, 2025 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 10, 2025 EAAU
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 6, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 6, 2025 GNSL
SUSPENSION LETTER WRITTEN
Aug 6, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 15, 2025 CNRT
ASSIGNED TO EXAMINER
May 7, 2025 DOCK
ASSIGNED TO EXAMINER
May 5, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 27, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2025 NWOS
NEW APPLICATION ENTERED
Jan 27, 2025 NWAP